GPT and fatty liver disease: Metabolic dysfunction-associated fatty liver disease was strongly correlated with BMI (rho = 0.402, P < .001), diabetes (rho = 0.115, P < .001), hypertension (rho = 0.146, P = .014), cholesterol (rho = 0.156, P < .001), LDL (rho = 0.230, P < .001), triglycerides (rho = 0.168, P < .001), and alanine aminotransferase (ALT) (rho = 0.238, P < .001).